CTCs in early breast cancer: A path worth taking

Roberta Maltoni, Giulia Gallerani, Pietro Fici, Andrea Rocca, Francesco Fabbri

Research output: Contribution to journalArticle

Abstract

Circulating tumor cells (CTCs) are cellular elements of undeniable significance that spread from the tumor mass into the peripheral blood and constitute one of the main vehicles for disease diffusion. Their rarity, in addition to a number of molecular and cellular features, has severely impaired research and exploitation. CTCs have been evaluated in early breast cancer (EBC), although long from being fully accepted in this field also due to a lack of technical standardization. CTCs hold promise to be a powerful non-invasive real-time measurable biomarker in all disease stages. This hypothesis is particularly appealing in the adjuvant setting of breast cancer, as it still lacks a marker that could play a central role in monitoring disease-free intervals, predicting early relapse and guiding drug selection. This review aimed to discuss CTC characteristics and show the main results of CTC-research in EBC setting, stating the urgency to continue basic and translational research in this field to definitely translate this marker from bench to bedside.

Original languageEnglish
Pages (from-to)205-210
Number of pages6
JournalCancer Letters
Volume376
Issue number2
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Circulating Neoplastic Cells
Breast Neoplasms
Translational Medical Research
Research
Biomarkers
Recurrence
Pharmaceutical Preparations
Neoplasms

Keywords

  • Circulating tumor cells
  • Clinical evidence
  • Early breast cancer
  • Liquid biopsy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CTCs in early breast cancer : A path worth taking. / Maltoni, Roberta; Gallerani, Giulia; Fici, Pietro; Rocca, Andrea; Fabbri, Francesco.

In: Cancer Letters, Vol. 376, No. 2, 01.07.2016, p. 205-210.

Research output: Contribution to journalArticle

Maltoni, Roberta ; Gallerani, Giulia ; Fici, Pietro ; Rocca, Andrea ; Fabbri, Francesco. / CTCs in early breast cancer : A path worth taking. In: Cancer Letters. 2016 ; Vol. 376, No. 2. pp. 205-210.
@article{3ccb97938dd64f31906d0b3f695e4771,
title = "CTCs in early breast cancer: A path worth taking",
abstract = "Circulating tumor cells (CTCs) are cellular elements of undeniable significance that spread from the tumor mass into the peripheral blood and constitute one of the main vehicles for disease diffusion. Their rarity, in addition to a number of molecular and cellular features, has severely impaired research and exploitation. CTCs have been evaluated in early breast cancer (EBC), although long from being fully accepted in this field also due to a lack of technical standardization. CTCs hold promise to be a powerful non-invasive real-time measurable biomarker in all disease stages. This hypothesis is particularly appealing in the adjuvant setting of breast cancer, as it still lacks a marker that could play a central role in monitoring disease-free intervals, predicting early relapse and guiding drug selection. This review aimed to discuss CTC characteristics and show the main results of CTC-research in EBC setting, stating the urgency to continue basic and translational research in this field to definitely translate this marker from bench to bedside.",
keywords = "Circulating tumor cells, Clinical evidence, Early breast cancer, Liquid biopsy",
author = "Roberta Maltoni and Giulia Gallerani and Pietro Fici and Andrea Rocca and Francesco Fabbri",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.canlet.2016.03.051",
language = "English",
volume = "376",
pages = "205--210",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - CTCs in early breast cancer

T2 - A path worth taking

AU - Maltoni, Roberta

AU - Gallerani, Giulia

AU - Fici, Pietro

AU - Rocca, Andrea

AU - Fabbri, Francesco

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Circulating tumor cells (CTCs) are cellular elements of undeniable significance that spread from the tumor mass into the peripheral blood and constitute one of the main vehicles for disease diffusion. Their rarity, in addition to a number of molecular and cellular features, has severely impaired research and exploitation. CTCs have been evaluated in early breast cancer (EBC), although long from being fully accepted in this field also due to a lack of technical standardization. CTCs hold promise to be a powerful non-invasive real-time measurable biomarker in all disease stages. This hypothesis is particularly appealing in the adjuvant setting of breast cancer, as it still lacks a marker that could play a central role in monitoring disease-free intervals, predicting early relapse and guiding drug selection. This review aimed to discuss CTC characteristics and show the main results of CTC-research in EBC setting, stating the urgency to continue basic and translational research in this field to definitely translate this marker from bench to bedside.

AB - Circulating tumor cells (CTCs) are cellular elements of undeniable significance that spread from the tumor mass into the peripheral blood and constitute one of the main vehicles for disease diffusion. Their rarity, in addition to a number of molecular and cellular features, has severely impaired research and exploitation. CTCs have been evaluated in early breast cancer (EBC), although long from being fully accepted in this field also due to a lack of technical standardization. CTCs hold promise to be a powerful non-invasive real-time measurable biomarker in all disease stages. This hypothesis is particularly appealing in the adjuvant setting of breast cancer, as it still lacks a marker that could play a central role in monitoring disease-free intervals, predicting early relapse and guiding drug selection. This review aimed to discuss CTC characteristics and show the main results of CTC-research in EBC setting, stating the urgency to continue basic and translational research in this field to definitely translate this marker from bench to bedside.

KW - Circulating tumor cells

KW - Clinical evidence

KW - Early breast cancer

KW - Liquid biopsy

UR - http://www.scopus.com/inward/record.url?scp=84962653571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962653571&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2016.03.051

DO - 10.1016/j.canlet.2016.03.051

M3 - Article

AN - SCOPUS:84962653571

VL - 376

SP - 205

EP - 210

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -